Marko Oblak
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cancer therapeutics and mechanisms 5
-
- Synthesis and biological activity 3
- Co-authors
- Tomaž Šolmajer (5 shared papers)Tom Šolmajer (8 shared papers)Roman Jerala (2 shared papers)Miha Kotnik (6 shared papers)Andreja Plaper (1 shared paper)Milan Randić (1 shared paper)U. Urleb (6 shared papers)Simona Golič Grdadolnik (2 shared papers)
In The Last Decade
Marko Oblak
16 papers receiving 705 citations
Peers
Comparison fields: 5 of 83
- Toxicology 89
- Molecular Medicine 115
- Biochemistry 74
- Organic Chemistry 196
- Molecular Biology 395
Countries citing papers authored by Marko Oblak
This map shows the geographic impact of Marko Oblak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Oblak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Oblak more than expected).
Fields of papers citing papers by Marko Oblak
This network shows the impact of papers produced by Marko Oblak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Oblak. The network helps show where Marko Oblak may publish in the future.
Co-authors
The 25 scholars most cited alongside Marko Oblak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 288 | |
| 2 | 2007 | 100 | |
| 3 | 2007 | 81 | |
| 4 | 2005 | 62 | |
| 5 | 2000 | 58 | |
| 6 | 2009 | 52 | |
| 7 | 2007 | 25 | |
| 8 | 2009 | 12 | |
| 9 | 2006 | 11 | |
| 10 | 2004 | 9 | |
| 11 | 2008 | 7 | |
| 12 | 2004 | 7 | |
| 13 | 2004 | 6 | |
| 14 | 2004 | 5 | |
| 15 | 2006 | 4 | |
| 16 | 2006 | 3 |
About Marko Oblak
Marko Oblak is a scholar working on Molecular Biology, Organic Chemistry, Toxicology, Computational Theory and Mathematics and Oncology, having authored 16 papers that have together received 730 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Computational Drug Discovery Methods (3 papers), Synthesis and biological activity (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Antibiotic Resistance in Bacteria (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Enzyme Structure and Function (2 papers). The work is most often cited by research in Toxicology (89 citations), Molecular Medicine (115 citations), Biochemistry (74 citations), Organic Chemistry (196 citations) and Molecular Biology (395 citations). Marko Oblak has collaborated with scholars based in Slovenia, Serbia and France. Frequent co-authors include Tomaž Šolmajer, Tom Šolmajer, Roman Jerala, Miha Kotnik, Andreja Plaper, Milan Randić, U. Urleb, Simona Golič Grdadolnik, Katja Kristan and Matjaž Brvar. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Molecular Modeling, Biochemical and Biophysical Research Communications, SLAS DISCOVERY and Current Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.